Skip to main content
Clinical Trials/CTRI/2022/08/044774
CTRI/2022/08/044774
Not yet recruiting
Phase 3

Comparative Evaluation of Anti-Depressant Activity of Mansyadi Capsule Vs Jyotishmati Capsule on Vishaad (Major Depressive Disorder)

Mahatma Gandhi Ayurveda College0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mahatma Gandhi Ayurveda College
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Mahatma Gandhi Ayurveda College

Eligibility Criteria

Inclusion Criteria

  • 1\.Males or females between the age of 30 to 55 years.
  • 2\.Subjects who will fulfill the DSM\-V criteria for the diagnosis of major depressive disorder without psychotic features and with single or recurrent episode for minimum two weeks.
  • 3\.Subjects who will be diagnosed as mild to moderate cases of MDD on Hamilton Depression Rating Scale.
  • 4\.Patients willing to give informed consent.
  • 5\.Females willing to follow methods of contraception during the course of trial.

Exclusion Criteria

  • 1\.Individuals at significant risk of suicide on the basis of the clinical judgement.
  • 2\.Pregnant, breast ââ?¬â??feeding or planning to become pregnant during the study.
  • 3\.Current history of illness with hepatic, renal, gastroenterological, respiratory, cardiovascular (including IHD), endocrinologic, neurologic, immunologic or hematological diseases and infectious diseases etc.
  • 4\.Significantly abnormal laboratory test and finding of electrocardiograph.
  • 5\.Current use of drug abuse or alcohol dependence.
  • 6\.Diagnosis of panic disorder, generalized anxiety, dementia, bipolar disorder, schizophrenia, or any other psychiatric disorders.

Outcomes

Primary Outcomes

Not specified

Similar Trials